drugset / Trial / NCT00003486

Antineoplaston Therapy in Treating Patients With Colon Cancer

NCT00003486

Phase 2 Withdrawn Burzynski Research Institute
Treatment

Summary

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with colon cancer.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject antineoplaston A10 Small molecule Oral
Subject antineoplaston AS2-1 Unknown Oral

Indications